“Sometimes the panic sets in,” Lyn Lessard said. “It’s the worst part of my job.”

Lessard handles drug purchasing for Rochester Regional Health’s Unity Hospital in Greece, where drug shortages -- many caused by manufacturing and supply problems -- have become routine.

“It really is the new normal,” Lessard said. “You have to find something to help these patients. You can’t put this on the back burner. It’s got to be the first thing that you’re working on, all the time.”

In this episode of Second Opinion LIVE, we take an in-depth look at the pharmaceuticals and nutraceuticals (supplements) that we are putting in our body. We discuss how we take them, if all are created equally, and if they are really making us healthier. Our guests:

  • Roger Oskvig, M.D., professor of clinical medicine and geriatrician at the University of Rochester Medical Center
  • Lisa Kuras, PharmD, clinical staff pharmacist at Highland Hospital

It's our monthly science roundtable! A University of Rochester chemistry professor just received a $1.5 million dollar NIH grant to study an alternate method of manufacturing pharmaceuticals. The results could lead to more options for patients -- a better chance to find something that works. It's also possible that we'll see cheaper drugs on the market, easier drug testing and trials, and more. We discuss the impacts of this with our panel: